Lybalvi
Payments companies reported to CMS as associated with Lybalvi. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Lybalvi, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Lybalvi
These are the largest totals companies reported as associated with Lybalvi. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Tarrah Holliday | Atlantic, IA | Psychiatric/Mental Health (Nurse Practitioner) | $1,314,175.95 |
| Kevin Ware | Columbus, OH | Psychiatry | $1,267,768.71 |
| Richard Price | Monsey, NY | Psychiatry | $1,151,144.17 |
| Rakesh Jain | Lake Jackson, TX | Psychiatry | $1,109,812.44 |
| Roger Rivera | Kissimmee, FL | Psychiatric/Mental Health (Nurse Practitioner) | $1,103,485.64 |
| George Kruse | Bronx, NY | Psychiatry | $1,084,493.46 |
| Andrew Cutler | Lakewood Ranch, FL | Psychiatry | $1,023,011.56 |
| Richard Jackson | Boca Raton, FL | Psychiatry | $985,955.64 |
| Rebecca Roma | Pittsburgh, PA | Psychiatry | $962,888.57 |
| Rakesh Amin | Nashville, TN | Psychiatry | $899,995.39 |
Prescribed Lybalvi?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.